Literature DB >> 16982791

Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.

Jamela Seedat1, Günther Zick, Ingo Klare, Carola Konstabel, Norbert Weiler, Hany Sahly.   

Abstract

We report the emergence of linezolid resistance (MICs of 16 to 32 mg/liter) in clonally related vancomycin-susceptible and -resistant Enterococcus faecium isolates from an intensive care unit patient after 12 days of linezolid therapy. Only linezolid-susceptible isolates of the same clone were detected at 28 days after termination of linezolid therapy.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16982791      PMCID： PMC1694002          DOI： 10.1128/AAC.00518-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  18 in total

1.  Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis.

Authors:  S H Marshall; C J Donskey; R Hutton-Thomas; R A Salata; L B Rice
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

2.  Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin.

Authors:  Issam I Raad; Hend A Hanna; Ray Y Hachem; Tanya Dvorak; Rebecca B Arbuckle; Gassan Chaiban; Louis B Rice
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

Review 3.  Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals.

Authors:  I Klare; C Konstabel; S Mueller-Bertling; G Werner; B Strommenger; C Kettlitz; S Borgmann; B Schulte; D Jonas; A Serr; A M Fahr; U Eigner; W Witte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

4.  Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid.

Authors:  R D Gonzales; P C Schreckenberger; M B Graham; S Kelkar; K DenBesten; J P Quinn
Journal:  Lancet       Date:  2001-04-14       Impact factor: 79.321

5.  Species identities of enterococci isolated from clinical specimens.

Authors:  K L Ruoff; L de la Maza; M J Murtagh; J D Spargo; M J Ferraro
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

Review 6.  A review of linezolid: the first oxazolidinone antibiotic.

Authors:  Dennis L Stevens; Brian Dotter; Karl Madaras-Kelly
Journal:  Expert Rev Anti Infect Ther       Date:  2004-02       Impact factor: 5.091

7.  Treatment of vancomycin-resistant enterococcus with quinupristin/dalfopristin and high-dose ampicillin.

Authors:  J Audis Bethea; Christine M Walko; Patricia A Targos
Journal:  Ann Pharmacother       Date:  2004-04-20       Impact factor: 3.154

8.  Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus.

Authors:  Venkata G Meka; Howard S Gold; Amy Cooke; Lata Venkataraman; George M Eliopoulos; Robert C Moellering; Stephen G Jenkins
Journal:  J Antimicrob Chemother       Date:  2004-09-03       Impact factor: 5.790

9.  A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin.

Authors:  Louis B Rice; Lenore Carias; Susan Rudin; Carl Vael; Herman Goossens; Carola Konstabel; Ingo Klare; Sreedhar R Nallapareddy; Wenxiang Huang; Barbara E Murray
Journal:  J Infect Dis       Date:  2003-01-08       Impact factor: 5.226

10.  Linezolid-resistant Enterococcus faecium and Enterococcus faecalis isolated from a septic patient: report of first isolates in Germany.

Authors:  E Halle; J Padberg; S Rosseau; I Klare; G Werner; W Witte
Journal:  Infection       Date:  2004-06       Impact factor: 3.553
View more
  13 in total

1.  In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.

Authors:  Laura Lawrence; Paul Danese; Joe DeVito; Francois Franceschi; Joyce Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  2008-03-03       Impact factor: 5.191

2.  Detection of mutations conferring resistance to linezolid in Enterococcus spp. by fluorescence in situ hybridization.

Authors:  Guido Werner; Melanie Bartel; Nele Wellinghausen; Andreas Essig; Ingo Klare; Wolfgang Witte; Sven Poppert
Journal:  J Clin Microbiol       Date:  2007-05-02       Impact factor: 5.948

3.  [Prevention and control of the spread of vancomycin-resistant enterococci: results of a workshop held by the German Society for Hygiene and Microbiology].

Authors:  R-P Vonberg; I F Chaberny; A Kola; F Mattner; S Borgmann; M Dettenkofer; D Jonas; A-M Fahr; I Klare; G Werner; K Weist; C Wendt; P Gastmeier
Journal:  Anaesthesist       Date:  2007-02       Impact factor: 1.041

4.  Flow cytometry approach study of Enterococcus faecalis vancomycin resistance by detection of Vancomycin@FL binding to the bacterial cells.

Authors:  Tomasz Jarzembowski; Agnieszka Jóźwik; Katarzyna Wiśniewska; Jacek Witkowski
Journal:  Curr Microbiol       Date:  2010-04-02       Impact factor: 2.188

5.  Use of linezolid in neonatal and pediatric inpatient facilities--results of a retrospective multicenter survey.

Authors:  A Simon; E Müllenborn; M Prelog; W Schenk; J Holzapfel; F Ebinger; A Klabunde-Cherwon; J Faber; A H Groll; K Masjosthusmann; C Dohna-Schwake; K Beutel; E Dirkwinkel; T Lehrnbecher; R A Ammann; A Müller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-03       Impact factor: 3.267

6.  R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.

Authors:  Eugene Skripkin; Timothy S McConnell; Joseph DeVito; Laura Lawrence; Joseph A Ippolito; Erin M Duffy; Joyce Sutcliffe; François Franceschi
Journal:  Antimicrob Agents Chemother       Date:  2008-07-28       Impact factor: 5.191

7.  Response to emerging infection leading to outbreak of linezolid-resistant enterococci.

Authors:  Marion A Kainer; Rose A Devasia; Timothy F Jones; Bryan P Simmons; Kelley Melton; Susan Chow; Joyce Broyles; Kelly L Moore; Allen S Craig; William Schaffner
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

8.  New antibiotics for antibiotic-resistant bacteria.

Authors:  William Stubbings; Harald Labischinski
Journal:  F1000 Biol Rep       Date:  2009-05-28

9.  Novel Structural Components Contribute to the High Thermal Stability of Acyl Carrier Protein from Enterococcus faecalis.

Authors:  Young-Guen Park; Min-Cheol Jung; Heesang Song; Ki-Woong Jeong; Eunjung Bang; Geum-Sook Hwang; Yangmee Kim
Journal:  J Biol Chem       Date:  2015-12-02       Impact factor: 5.157

10.  Syntheses and biological studies of novel spiropiperazinyl oxazolidinone antibacterial agents using a spirocyclic diene derived acylnitroso Diels-Alder reaction.

Authors:  Cheng Ji; Weimin Lin; Garrett C Moraski; Jane A Thanassi; Michael J Pucci; Scott G Franzblau; Ute Möllmann; Marvin J Miller
Journal:  Bioorg Med Chem       Date:  2012-04-18       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.